purchased from Miles Laboratories Inc., Miles Research Products, Elkhart, Ind. and Escherichia coli lipopolysaccharide (LPS) was bought from Difco Laboratories, Detroit, Mich. Horse erythrocytes (HRBC) from a single animal were provided by the Colorado Serum Co., Denver, Colo. A trinitrophenylated form of each of these antigens was prepared as previously described (11) .
Immunizations. KLH-or (TG)-A--L-specifie helper T cells were obtained from animals immunized as previously described (11) . To ensure that the appropriate antigen-presenting cells were present in B10.M ~ (B10 X B10.M)F1 chimeric mice, these animals were given one mouse equivalent each of (B10 × B10.M)F1 or B10 B cells and M~ i.v. on the day of priming. B cells and M~ were prepared free of T cells by injection of donor animals with 0.04 ml ATS i.p. 2 d before transfer, and treatment of combined splenic and peritoneal cells with anti-T serum and complement (10) immediately before transfer. This is a procedure which we have shown in the past supplies antigen-presenting cells of the required haplotype to parental --* F1 chimeric mice (1) . For in vitro immunizations antigen was added as previously described (11) .
Preparation of T Cells, B Cells, and Macrophages. T cells were isolated from nylon fiber columns as previously described (10) . Where necessary these cells were depleted of BI0 or (B10 X B10.M)Ft cells by treatment with B10.A anti-B10 serum followed by washing and incubation with rabbit complement (1). The antiserum selected for this treatment had a high cytotoxic titer on H-2 b lymphoeytes and no discernable cytotoxicity on H-2 t lymphocytes. Erythrocytes were removed from splenic T-cell preparations before antiserum and complement treatment using modified Gey's solution (14) . B cells and Mq~ were obtained from the spleens of TNP-LPS-primed mice by treatment with anti-T-cell serum and complement (10) . M4~ for presentation of TNP-(TG)-A--L were obtained from the peritoneal washings of normal mice, and pulsed with TNP-(TG)-A--L as previously described (11) . When T cells were treated with antisera, the T-cell activities reported are based on the original number of T cells before treatment.
Assay of Helper T-Cell
Anti-TNP PFC were assayed from triplicate cultures using the slide modification of the hemolytic plaque assay (10) . Parallel determinations were made with HRBC and TNP-HRBC and the difference recorded as the number of anti-TNP specific PFC.
Results
We tested the ability of T cells from B experiments, chimeric and Fa T cells were treated with anti-H-2 b serum and complement to prove that the response observed in chimeric animals was indeed a result of T cells bearing H-2 f antigens only. We were concerned that we had not successfully reconstituted the chimeric animals with high responder H-2b-bearing antigen-presenting cells. To prove that such cells were indeed functional we performed concomitant experiments to those described above, using B10.M ---) (B10 X B10.M)F1 chimeric mice given H-2b-bearing B cells and M#) on the day of immunization (see above) and primed with KLH. T cells from these animals were able to help anti-TNP-KLH responses of B10 or B10.M B cells and M(/) very well, and had as high a helper activity as KLH-primed cells from (B10 × BI0.M)F1 animals (Fig. 2) . Again, controls after T-cell treatment with anti-H-2 b serum and complement revealed that the KLH-specific helper activity in the chimeric mice was a result of T cells of donor origin. There are a number of possible explanations for the expression of lr genes in helper T cells. Many experiments from this (7, (9) (10) (11) and other (8, 15, 16) laboratories have shown that/r-genes are expressed in B cells and Mth in a manner consistent with the idea that these genes control the recognition of B-cell-or Mth-bound antigen by T cells. By analogy, it may be, as suggested by Zinkernagel et al. (17) and von Boehmer et al. (5) , that/r-genes, expressed in helper T cells, control the recognition of helper T-cell-bound antigen by a second T cell whose activity is required for the response of the helper T cell. The attraction to us of such an explanation is it produces a unifying scheme for the mode of action of/r-genes.
On the other hand, there are other explanations for our results which our data at present do not distinguish. For example, a second possibility is that some Ir-gene products are involved in the structure of the T-cell receptor for antigen and therefore, the expression of a low responder Ir-gene in H-2 f T cells indicates the lack of (T,G)-A--L-specific receptors in mice of this haplotype. A third possibility is that an Ir-gene controlling (W,G)-A--L-specific suppressor cells is expressed in mice of the H-2 t but not H-2 ~ haplotype. Our future experiments will be aimed at distinguishing these various possibilities.
Summary
We examined the expression of (TG)-A--L specific Ir genes in helper T cells using T cells from low responder ~ (B10, high responder × low responder) F1 chimeric mice. In this paper, the low responder strain studied was B10.M, Taken together with our previous findings that (TG)-A--L-specific Ir genes are expressed by B cells and M~b of both the H-2 ~ and H-2 t haplotypes, the results indicate two sites of action for Ir genes, and suggest two different gene products acting at different stages of the response, both of which are defective in H-2 f cells, and only one of which is defective in H-2 ~ cells.
